Summary
Performance
Immunogen
Application
Background
This gene encodes a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. The encoded protein plays a central role in high density lipoprotein (HDL) and very low density lipoprotein (VLDL) metabolism. This protein has also been shown to inhibit cholesteryl ester transfer protein in plasma. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Sep 2016],function:Appears to modulate the interaction of APOE with beta-migrating VLDL and inhibit binding of beta-VLDL to the LDL receptor-related protein.,miscellaneous:Apo-CI makes up about 10% of the protein of the VLDL (very low density lipoprotein) and 2% of that of HDL (high density lipoprotein).,online information:Apolipoprotein C1 entry,similarity:Belongs to the apolipoprotein C1 family.,tissue specificity:Synthesized mainly in liver and to a minor degree in intestine. Secreted in plasma.,
Research Area
Cardiovascular; Lipids / Lipoproteins; Lipoproteins/Apolipoproteins; Lipoproteins; Fatty Acids; Binding proteins; Signal Transduction; Metabolism; Lipid metabolism; Atherosclerosis; Lipoprotein metabolism; Metabolism Pathways and Processes; Metabolic signaling pathways; Lipid and lipoprotein metabolism; Heart disease; Pathways and Processes; Redox metabolism; Fatty acid oxidation
